Phase 2
Completed N=31
Memory and Insulin in Early Alzheimer's Disease
Source: ClinicalTrials.gov NCT00581867 ↗Enrolled (actual)
31
Serious AEs
1.7%
Results posted
Jul 2015
Primary outcomePrimary: fMRI Measure of Hippocampal Activation — 36.4; 41.3 percentage of active voxels
Summary
To determine which parts of the brain are involved in insulin-related memory improvement in early Alzheimer's disease and cognitively normal older adults.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY fMRI Measure of Hippocampal Activation |
36.4; 41.3 | — |
| SECONDARY Global Cognition |
-.05; -.02 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with Early Alzheimer's disease
Exclusion Criteria
- Patients with Late Alzheimer's disease
Data sourced from ClinicalTrials.gov (NCT00581867). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.